Cas:756526-02-0 Fmoc-N-amido-PEG8-acid manufacturer & supplier

We serve Chemical Name:Fmoc-N-amido-PEG8-acid CAS:756526-02-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Fmoc-N-amido-PEG8-acid

Chemical Name:Fmoc-N-amido-PEG8-acid
CAS.NO:756526-02-0
Synonyms:5,8,11,14,17,20,23,26-Octaoxa-2-azanonacosanedioic acid, 1-(9H-fluoren-9-ylmethyl) ester;1-(9H-fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28-nonaoxa-4-azahentriacontan-31-oic acid;Fmoc-N-amido-PEG8-acid
Molecular Formula:C34H49NO12
Molecular Weight:663.75200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.190±0.06 g/cm3
Index of Refraction:
PSA:149.47000
Exact Mass:663.32500
LogP:3.52350

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5,8,11,14,17,20,23,26-Octaoxa-2-azanonacosanedioic acid, 1-(9H-fluoren-9-ylmethyl) ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Fmoc-N-amido-PEG8-acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(9H-fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28-nonaoxa-4-azahentriacontan-31-oic acid Use and application,1-(9H-fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28-nonaoxa-4-azahentriacontan-31-oic acid technical grade,usp/ep/jp grade.


Related News: “This is the beginning of the next chapter of growth for BetterUp, and we are not slowing down” 2-[(2R,3R)-2-Benzoylsulfanyl-4-oxo-3-(2-phenoxy-acetylamino)-azetidin-1-yl]-3-methyl-but-2-enoic acid methyl ester manufacturers The FDA in announcing its approval noted that four, 12-week placebo-controlled clinical studies that included a total of 1,143 participants showed Nourianz offered a statistically significant decrease from baseline in daily “off” time compared to those on placebo. 1-(3,5-O-Isopropylidene-2-deoxy-β-D-threo-pentofuranosyl)thymine suppliers A possible reason for this is that developments within the biocatalysis field have fast outpaced existing knowhow, leaving some pharmaceutical companies unaware of the vast range of options available. Keeping abreast of both current and emerging developments within the field of biocatalytic processing is key when it comes to maintaining a competitive edge. Bis-(dipalmitoyl-DL-α-glycerylphosphoryl)-1,3-propandiol vendor & factory.